EPIGENETICS DRUGS & DIAGNOSTIC TECHNOLOGIES MARKET ANALYSIS (2020-2027)

1

• Coherent Market Insights
• Market Research and Business Consulting Services
• https//www.coherentmarketinsights.com/
• COVID-19 Impact Tracker

2
EPIGENETICS DRUGS DIAGNOSTIC TECHNOLOGIES
MARKET ANALYSIS (2020-2027)

• Epigenetics Drugs Diagnostic Technologies
  Market, By Type (Epigenetic Drugs (DNMT
  Inhibitors (Azacitidine, Decitabine), HDAC
  Inhibitors (Vorinostat, Romidepsin)), Epigenetics
  Diagnostic Technologies (DNA Methylation, ChIP
  Technology)), and By Region (North America, Latin
  America, Europe, Asia Pacific, Middle East
  Africa) - Size, Share, Outlook, and Opportunity
  Analysis, 2020 - 2027

3

• Epigenetics can be defined as the study of
  chemical modifications of some specific genes of
  an organism. A gene can be altered with change in
  the sequence of its DNA or epigenetic
  programming. Epigenetic drugs make it possible to
  reverse the aberrant gene expression which leads
  to various disease states.

4
Statistics

• The global epigenetic drugs and diagnostic
  technologies market is estimated to account
  for US 28,606.6 Mn in terms of value by the end
  of 2027.

5
Global Epigenetic Drugs and Diagnostic
Technologies Market Drivers

• Increasing prevalence of cancer is expected to
  propel growth of the global epigenetic drugs and
  diagnostic technologies market over the forecast
  period. For instance, according to the American
  Cancer Society, in 2019, there will be an
  estimated 1,762,450 new cancer cases diagnosed
  and 606,880 cancer deaths in the U.S.
• Moreover, RD in epigenetic drugs is also
  expected to aid in growth of the market. For
  instance, the study, Vorinostat in the acute
  neuroinflammatory form of X?linked
  adrenoleukodystrophy, published in May 2020, in
  Annals of Clinical and Translational Neurology,
  reported that treatment with certain epigenetic
  medicines may help compensate for a deficiency in
  the ABCD1 gene in patients with
  adrenoleukodystrophy.

6
Statistics

• North America held dominant position in the
  global epigenetic drugs and diagnostic
  technologies market in 2019, accounting
  for 40.8 share in terms of value, followed by
  Europe and Asia Pacific, respectively.

7
Figure 1 Global Epigenetic Drugs and Diagnostic
Technologies Market Share () Value, By Region,
2019
8
Global Epigenetic Drugs and Diagnostic
Technologies Market Restraints

• Longer durations of RD for developing epigenetic
  drugs is expected to hinder growth of the market.
  It takes a new drug 12 years to go from research
  lab to patient, with many thousands of candidates
  discarded along the way.
• Moreover, lack of evidence regarding the efficacy
  of epigenetic therapy in solid tumors is also
  expected to limit the market growth.

9
(No Transcript)
10
Global Epigenetic Drugs and Diagnostic
Technologies Market Opportunities 

• Funding for RD in epigenetics is expected to
  offer lucrative growth opportunities for players
  in the global epigenetic drugs and diagnostic
  technologies market. For instance, in June 2020,
  The University of Illinois at Chicago, U.S.,
  received US 8.2 million from the National
  Institute on Alcohol Abuse and Alcoholism to
  continue the Center for Alcohol Research in
  Epigenetics and its research on how alcohol
  affects genes through epigenetics.

11

• Moreover, development machine-learning algorithms
  to aid in epigenetic drug discovery is also
  expected to boost the market growth. For
  instance, in October 2019, researchers at Sanford
  Burnham Prebys Medical Discovery Institute, U.S,
  developed a machine-learning algorithm that
  gleans information from microscope images in
  order to allow high-throughput epigenetic drug
  screens.

12
Statistics

• The global epigenetic drugs and diagnostic
  technologies market was valued at US 6,800.3
  Mn in 2019 and is forecast to reach a value
  of US 28,606.6 Mn by 2027 at a CAGR of
  19.7 between 2020 and 2027.

13

• Figure 2 Global Epigenetic Drugs and Diagnostic
  Technologies Market Value (US Mn), 2016 2027

14
Market Trends/Key Takeaways

• The market is witnessing RD of novel epigenetic
  drugs. For instance, in November 2019,
  researchers with the Pasteur Institute and CNRS
  (French National Center for Scientific Research),
  France, reported identifying epigenetic
  inhibiting drugs that can inhibit DNA methylation
  and eliminate even the most resistant of the
  malaria parasites, Plasmodium falciparum, in the
  journal ACS Central Science.
• The market is also witnessing entry of new
  players. For instance, in September 2019, Omega
  Therapeutics, a biotech startup, announced its
  entry in RD of medicines based on epigenetics.

15
Global Epigenetic Drugs and Diagnostic
Technologies Market Competitive Landscape

• Major players operating in the global epigenetic
  drugs and diagnostic technologies market include,
  4SC AG, Acetylon Pharmaceuticals, Inc., Astex
  Pharmaceuticals Inc., CellCentric Ltd., Celleron
  Therapeutics Ltd., Celgene Corporation, Chroma
  Therapeutics Ltd., Epigentek Group Inc., Eisai
  Co. Ltd., EnVivo Pharmaceuticals Inc., Base
  Genomics, and Oryzon Genomics, S.A.

16
Global Epigenetic Drugs and Diagnostic
Technologies Market Key Developments

• Major players in the market are focused on
  launching new products to expand their product
  portfolio. For instance, in July 2020, EpiGentek
  launched a series of SARS-CoV-2 research assays
  in combatting the ongoing COVID-19 pandemic.
• Major players in the market are also focused on
  adopting collaboration strategies to expand their
  product portfolio. For instance, in June 2020,
  Oryzon Genomics, S.A., a clinical-stage
  biopharmaceutical company leveraging epigenetics
  for RD of new therapies, collaborated with
  Institute of Medical and Molecular Genetics
  (INGEMM) of the La Paz University Hospital in
  Madrid for RD of precision medicine in patients
  with Phelan-McDermid Syndrome.

17

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Buy Now
• Reference https//www.coherentmarketinsights.com/
  market-insight/epigenetics-drugs-and-diagnostic-te
  chnologies-market-4026

18
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions.
• What we provide
• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

19
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt.Ltd.
• Address 1001 4th Ave, 3200 Seattle, WA 98154,
  U.S.
• Phone [phone]
• Email sales_at_coherentmarketinsights.com

20

• Thank You!
• Kindly follow CMI Social Media
  Profiles for the latest company updates
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/